Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-52,553
Closed -$4.22M 952
2025
Q2
$4.22M Buy
52,553
+4,724
+10% +$342K 0.01% 595
2025
Q1
$3.46M Sell
47,829
-33,653
-41% -$2.52M 0.01% 623
2024
Q4
$6.23M Buy
81,482
+26,716
+49% +$2.24M 0.02% 484
2024
Q3
$4.85M Sell
54,766
-4,254
-7% -$375K 0.01% 554
2024
Q2
$5.07M Sell
59,020
-69,303
-54% -$6.17M 0.02% 534
2024
Q1
$12.3M Buy
128,323
+109,729
+590% +$9.5M 0.04% 375
2023
Q4
$1.5M Sell
18,594
-89,353
-83% -$6.93M ﹤0.01% 784
2023
Q3
$8.43M Sell
107,947
-47,800
-31% -$3.56M 0.03% 416
2023
Q2
$10.5M Sell
155,747
-24,400
-14% -$1.61M 0.04% 399
2023
Q1
$12.7M Buy
+180,147
New +$12.8M 0.04% 371

Other funds holding TXT

Axa's TXT Position: Q3 2025 in Review

Axa sold out of Textron (TXT) in Q3 2025, closing a stake of 52,553 shares — an estimated $4.22M sold.

Axa first reported a position in TXT in Q1 2023 and held it in 10 quarters. The position peaked at $12.7M in Q1 2023. 682 funds tracked by Wall St. Rank hold TXT as of Q3 2025.

  • Axa reported no remaining Textron position as of Q3 2025 after selling out during the quarter.
  • Axa sold 52,553 Textron shares in Q3 2025, an estimated $4.22M.
  • Axa first reported a position in Textron in Q1 2023 and held it in 10 quarters.
  • Axa's Textron position peaked at $12.7M in Q1 2023.
  • 682 funds tracked by Wall St. Rank held Textron as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.